What we do: Offspring Biosciences provides contract research services to the Pharma and Biotech industry, using advanced histopathology-based analytical techniques. Who we are The company is managed by Anders Ericsson-Dahlstrand, Dan Sunnemark and Anne Svensson, former senior scientists at AstraZeneca's now closed R&D unit in Södertälje, Sweden. We bring extensive and solid experience supporting drug discovery teams targeting neurodegenerative diseases (Alzheimers, Parkinsons and Huntingtons disease), diabetes and oncology, with highly informative and reliable data for critical Stop/Go decisions. Our services - Full study deliveries (design, execution, analyses and reporting) - Target validation studies in tissues from pre-clinical disease models and in human tissue - Profiling of drug binding properties, including demonstrating target engagement and performing tissue cross reactivity analyses - Evaluating effects in pre-clinical drug treatment studies - Evaluating side effect risks - Supporting translational research activites - Animal and human tissue sourcing, validation and characterization - Crititical review of literature data regarding quality, gap and risk - Extended services via strategic collaborations (eg tissue banking, in vivo pharmacology, bioanalysis, radiochemistry, whole body autoradiography, human and veterinary pathology) - Right Target - Right Drug - Right Efficacy - Right Safety For further information, please visit our website www.offspringbiosciences.se or contact us at: contact@offspringbiosciences.se